Xeinadin growth continues with second acquisition of 2023 

Clear Vision Financial Management

Date:

Category:

Share this article:

Xeinadin, one of the leading professional services firms in the UK and Ireland, has announced the acquisition of Clear Vision Financial Management.   

Clear Vision Financial Management is a Hampshire-headquartered accountancy and advisory firm founded in 2011 by founding Director and Chartered Management Accountant Sean Daniel. It specialises in providing services such as outsourced finance functions, R&D Tax Credits, Finance Director and financial business strategy, accounts and tax compliance services, and pension and payroll services. 

The move marks Xeinadin’s second acquisition announced in 2023, following its announcement of Poppleton and Appleby joining the firm last week as the continues its strong growth journey. Xeinadin has a strong pipeline for continued expansion as it attracts more and more small and medium-sized firms to its family. 

Xeinadin is a firm of business advisory and accountancy practices in over 120 locations across the UK and Ireland. It provides over 40 service lines to over 50,000 clients, predominantly small and medium-sized businesses and their owner-managers.  

Derry Crowley, CEO, Xeinadin, said: “We are looking forward to having the Clear Vision team on board. They bring added strength in services such as R&D Tax Credits as well as providing an outsourced finance function for many companies. This is a great start to the year for Xeinadin and we are starting as we mean to go on, bringing in excellent firms to our company.” 

Sean Daniel, said: “We are proud to be joining Xeinadin and looking forward to the year ahead where we can share knowledge and best practice from our areas of expertise across our new colleagues, giving us the opportunity to work with new clients as well as strengthening the portfolio of services we can offer our clients and strengthening our processes and infrastructure.”  

This website uses cookies

With these cookies, we and third parties can collect information about you and your internet behaviour, both within and outside our website. Based on this, we and third parties adjust the website, our communication, and advertisements to your interests and profile. You can read more information in our cookie statement.

If you opt for acceptance, we will place all cookies. If you opt for rejection, we will only place functional and analytical cookies. You can adjust your preferences at a later time.

Accept Reject More options

This website uses cookies

With these cookies, we and third parties can collect information about you and your internet behaviour, both within and outside our website. Based on this, we and third parties adjust the website, our communication, and advertisements to your interests and profile. You can read more information in our cookie statement.

Functional cookies
Arrow down

Functional cookies are essential for the proper functioning of our website. They allow us to enable basic functions such as page navigation and access to secure areas. These cookies do not collect personal information and cannot be disabled.

Analytical cookies
Arrow down

Analytical cookies help us gain insight into how visitors use our website. We collect anonymised data about page interactions and navigation, enabling us to continuously improve our site.

Marketing cookies
Arrow down

Marketing cookies are used to track visitors when they visit different websites. The goal is to display relevant advertisements to the individual user. By allowing these cookies, you help us show you relevant content and offers.

Accept all Save

Name

Subtitle
Developer
Location
They are focussed on creating a future-focused and relationship-driven culture, that keeps its promises to you, our team members, and partners.
Xeinadin